- In August 2022, Bioventus Inc., a global leader in innovations for active healing, has announced that the U.S. Food and Drug Administration (FDA) has granted 510(k) clearance for its neXus SonaStar Elite handpiece. The SonaStar Elite (SSE) handpiece is part of the neXus Ultrasonic Surgical Aspirator System, an advanced integrated ultrasonic surgical platform that utilizes a proprietary digital algorithm, offering enhanced versatility and control
- In August 2022, Bioventus Inc. announced that its nexus SonaStar Elite handpiece received FDA 510(k) clearance as part of the neXus Ultrasonic Surgical Aspirator System — an integrated platform designed for optimized soft‑ and hard‑tissue removal in neurosurgery, offering enhanced precision at 36 kHz operation
- In December 2021, Bioventus also secured FDA 510(k) clearance for its neXus BoneScalpel Access handpiece—expanding its ultrasonic surgical aspirator platform with an option for precise bone removal in confined spaces, particularly suited for minimally invasive neurosurgical procedures
